ArticleThe oncologist2020
HER2 Overexpression as a Poor Prognostic Determinant in Resected Biliary Tract Cancer.
Caterina Vivaldi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
33 papers cite it
this paperpooled ittrialcites it